{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:51:11Z","timestamp":1787064671448,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>The number of patients dialyzed for ESKD exceeds 500,000 in the United States and more than 2.6 million people worldwide, with the expectation that the worldwide number will double by 2030. The human cost of health and societal financial cost of ESKD is substantial. Dialytic therapy is associated with an unacceptably high morbidity and mortality rate and poor quality of life. Although innovation in many areas of science has been transformative, there has been little innovation in dialysis or alternatives for kidney replacement therapy (KRT) since its introduction approximately 70 years ago. Advances in kidney biology, stem cells and kidney cell differentiation protocols, biomaterials, sensors, nano\/microtechnology, sorbents and engineering, and interdisciplinary approaches and collaborations can lead to disruptive innovation. The Kidney Health Initiative, a public\u2013private partnership between the American Society of Nephrology and the US Food and Drug Administration, has convened a multidisciplinary group to create a technology roadmap for innovative approaches to KRT to address patients\u2019 needs. The Roadmap is a living document. It identifies the design criteria that must be considered to replace the myriad functions of the kidney, as well as scientific, technical, regulatory, and payor milestones required to commercialize and provide patient access to KRT alternatives. Various embodiments of potential solutions are discussed, but the Roadmap is agnostic to any particular solution set. System enablers are identified, including vascular access, biomaterial development, biologic and immunologic modulation, function, and safety monitoring. Important Roadmap supporting activities include regulatory alignment and innovative financial incentives and payment pathways. The Roadmap provides estimated timelines for replacement of specific kidney functions so that approaches can be conceptualized in ways that are actionable and attract talented innovators from multiple disciplines. The Roadmap has been used to guide the selection of KidneyX prizes for innovation in KRT.<\/jats:p>","DOI":"10.2215\/cjn.02570319","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T13:55:17Z","timestamp":1569592517000},"page":"1539-1547","source":"Crossref","is-referenced-by-count":60,"title":["A Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies"],"prefix":"10.2215","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-386X","authenticated-orcid":false,"given":"Joseph V.","family":"Bonventre","sequence":"first","affiliation":[{"name":"Division of Renal Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"},{"name":"Harvard Stem Cell Institute, Cambridge, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9184-1814","authenticated-orcid":false,"given":"Frank P.","family":"Hurst","sequence":"additional","affiliation":[{"name":"Center for Devices and Radiological Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"West","sequence":"additional","affiliation":[{"name":"American Society of Nephrology, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwen","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabir","family":"Roy-Chaudhury","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; and"},{"name":"Department of Medicine, WG (Bill) Hefner VA Medical Center, Salisbury, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Sheldon","sequence":"additional","affiliation":[{"name":"Center for Devices and Radiological Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","article-title":"Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy","volume":"390","author":"Levin","year":"2017","journal-title":"Lancet"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: A systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2215\/CJN.11861112","article-title":"Can we improve quality of life of patients on dialysis?","volume":"8","author":"Jaar","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"e1001307","DOI":"10.1371\/journal.pmed.1001307","article-title":"A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments","volume":"9","author":"Wyld","year":"2012","journal-title":"PLoS Med"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1200\/JCO.18.02037","article-title":"Annual Report on Progress Against Cancer From the American Society of Clinical Oncology","volume":"37","author":"Pal","year":"2019","journal-title":"J Clin Oncol"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.kint.2016.10.033","article-title":"Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis","volume":"91","author":"Garg","year":"2017","journal-title":"Kidney Int"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.01140113","article-title":"Fostering innovation, advancing patient safety: The kidney health initiative","volume":"8","author":"Archdeacon","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1681\/ASN.2015090976","article-title":"Overcoming barriers in kidney health-forging a platform for innovation","volume":"27","author":"Linde","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/j.ajkd.2017.03.013","article-title":"Stimulating patient engagement in medical device development in kidney disease: A report of a kidney health initiative workshop","volume":"70","author":"Hurst","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tibtech.2017.09.006","article-title":"Emerging biomedical applications of enzyme-like catalytic nanomaterials","volume":"36","author":"Cormode","year":"2018","journal-title":"Trends Biotechnol"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1039\/C7LC00914C","article-title":"Wearable sensors: Modalities, challenges, and prospects","volume":"18","author":"Heikenfeld","year":"2018","journal-title":"Lab Chip"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5435\/JAAOS-20-06-383","article-title":"Implantable sensor technology: From research to clinical practice","volume":"20","author":"Ledet","year":"2012","journal-title":"J Am Acad Orthop Surg"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NSA.S43773","article-title":"Innovations in nanotechnology for water treatment","volume":"8","author":"Gehrke","year":"2015","journal-title":"Nanotechnol Sci Appl"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"0069","DOI":"10.1038\/s41551-017-0069","article-title":"Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip","volume":"1","author":"Musah","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"34845","DOI":"10.1038\/srep34845","article-title":"Bioprinting of 3D convoluted renal proximal tubules on perfusable chips","volume":"6","author":"Homan","year":"2016","journal-title":"Sci Rep"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1038\/ncomms9715","article-title":"Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids","volume":"6","author":"Freedman","year":"2015","journal-title":"Nat Commun"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nbt.3392","article-title":"Nephron organoids derived from human pluripotent stem cells model kidney development and injury","volume":"33","author":"Morizane","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1006\/bbrc.2001.6214","article-title":"Calcium-dependent oxidation of thioredoxin during cellular growth initiation","volume":"290","author":"Gitler","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/xen.12161","article-title":"Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1\/CMAH\/\u03b24GalNT2 genes","volume":"22","author":"Estrada","year":"2015","journal-title":"Xenotransplantation"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12033-017-0024-9","article-title":"Genetically modified pigs as organ donors for xenotransplantation","volume":"59","author":"Hryhorowicz","year":"2017","journal-title":"Mol Biotechnol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aad1191","article-title":"Genome-wide inactivation of porcine endogenous retroviruses (PERVs)","volume":"350","author":"Yang","year":"2015","journal-title":"Science"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.stem.2016.07.018","article-title":"Contributions of mammalian chimeras to pluripotent stem cell research","volume":"19","author":"Mascetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-018-0765-z","article-title":"Consistent success in life-supporting porcine cardiac xenotransplantation","volume":"564","author":"L\u00e4ngin","year":"2018","journal-title":"Nature"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41467-019-08394-9","article-title":"Generation of pluripotent stem cell-derived mouse kidneys in Sall1-targeted anephric rats","volume":"10","author":"Goto","year":"2019","journal-title":"Nat Commun"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.02570319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:16Z","timestamp":1786369156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.02570319"}},"subtitle":["A Catalyst for Change"],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02570319","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}